Ghrhr

1 study on Ghrhr mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.

2026-04-03 PubMed · preclinical animal · n preclinical

GHRH Antagonist JMR-132 Blocks Both ER-Positive and ER-Negative Breast Cancer Cell Proliferation

**GHRH antagonism via JMR-132 may represent a receptor-status-agnostic therapeutic axis in breast cancer**, addressing a major clinical gap: ER-negative tumors have few hormone-based treatment options. The dual activi…

TitrateLab

You must be 21 or older to enter.

TitrateLab provides research-use information on peptides for adults. Confirm your age to continue.

For research purposes only. Not for human consumption. By entering you agree to our Terms & Privacy.